Synthetic Biologics Names Dr. Mark Pimentel Chairman of IBS Advisory Board

Share on Facebook
Synthetic Biologics appointed gastroenterologist Mark Pimentel, MD, chairman of its new irritable bowel syndrome clinical advisory board.

The advisory board will serve to support the development of the company's constipation-predominant IBS program. Dr. Pimentel led the team whose discoveries form the foundation of the C-IBS program.

Dr. Pimentel is an associate professor of medicine at Cedars-Sinai Medical Center in Los Angles.

More Articles on Gastroenterology:
CO2 Insufflation vs. Air Insufflation in Enteroscopy
The Best Opportunities for Quality Improvement Projects in Gastroenterology
Are More Gastroenterologists Participating in ACOs?

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


New from Becker's ASC Review

Are surveillance colonoscopy practices due for an update?

Read Now